TVAMP
MRNA icon

Tennessee Valley Asset Management Partners’s Moderna MRNA Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-727
Closed -$280K – 98
2021
Q3 		$280K Buy
+727
New +$268K 0.11% 64
2021
Q2 		– Sell
-3,806
Closed -$498K – 76
2021
Q1 		$498K Buy
+3,806
New +$552K 0.13% 63

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tennessee Valley Asset Management Partners's MRNA Position: Q4 2021 in Review

Tennessee Valley Asset Management Partners sold out of Moderna (MRNA) in Q4 2021, closing a stake of 727 shares — an estimated $280K sold.

Tennessee Valley Asset Management Partners first reported a position in MRNA in Q1 2021 and held it in 2 quarters. The position peaked at $498K in Q1 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Tennessee Valley Asset Management Partners reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Tennessee Valley Asset Management Partners sold 727 Moderna shares in Q4 2021, an estimated $280K.
  • Tennessee Valley Asset Management Partners first reported a position in Moderna in Q1 2021 and held it in 2 quarters.
  • Tennessee Valley Asset Management Partners's Moderna position peaked at $498K in Q1 2021.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q4 2021, filed 14 Feb 2022.